Iran, first MidEast country to join Int’l pharmaceutical regulatory body

In a bid to increase the quality of the medicine produced in Iran, the country has been allowed as an observer member into the ICH, which oversees pharmaceutical production all over the world.

17 December 2018
ID : 1703
Share
Share with
Telegram Whatsapp
Link
In a bid to increase the quality of the medicine produced in Iran, the country has been allowed as an observer member into the ICH, which oversees pharmaceutical production all over the world.

Iranian pharmaceutical company, Abidi Pharmaceuticals.

The International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) admitted Iran as an observer member in its November assembly. 

Iran is the first country in the Middle East region to join the ICH, an organisation that works toward the unification of quality, efficiency and safety standards for pharmaceuticals across the world. 

Being a member can help increase the quality of pharmaceuticals produced in the country and ease the exports of such products from Iran to other countries.

ICH started activity in 1990 and currently has 16 members and 28 observer members.

Topics:
Comment
Reply to :
= 5-4
Related